<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1002/(ISSN)1868-1751" xmlns="http://purl.org/rss/1.0/"><title>Molecular Informatics</title><description> Wiley Online Library : Molecular Informatics</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2F%28ISSN%291868-1751</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Copyright © 2013 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1868-1743</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1868-1751</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">April 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">32</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">4</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">317</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">398</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1002/minf.v32.4/asset/cover.gif?v=1&amp;s=49b95251547c443c1f808ef8f1c7549300827ea6"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200166"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200167"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300004"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300020"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200117"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200120"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390007"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390008"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300042"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200154"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200142"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300006"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300008"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200128"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200169"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200166" xmlns="http://purl.org/rss/1.0/"><title>The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200166</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hai Pham-The, Isabel González-Álvarez, Marival Bermejo, Teresa Garrigues, Huong Le-Thi-Thu, Miguel Ángel Cabrera-Pérez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T15:12:12.342318-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200166</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200166</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200166</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>During the early ADME profiling the development of simple, interpretable and reliable in silico tools is very important. In this study, rule-based and QSPR approaches were investigated using a large Caco-2 permeability database. Three permeability classes were determined: high (H), moderate (M) and low (L). The main physicochemical properties related with permeability were ranked as follows: Polar Surface Area (<em>PSA</em>)&gt;Lipophilicity (log<em>P</em>/log<em>D</em>)&gt;Molecular Weight (<em>MW</em>)&gt;number of Hydrogen Bond donors and acceptors&gt;Ionization State&gt;number of Rotatable Bonds&gt;number of Rings. The best rule, based on the combination of <em>PSA</em>-<em>MW</em>-log<em>D</em> (3PRule), was able to identify the H, M and L classes with accuracy of 72.2, 72.9 and 70.6 %, respectively. Subsequently, a consensus system based on three voting binary classification trees was constructed. It accurately predicted 78.4/76.1/79.1 % of H/M/L compounds on training and 78.6/71.1/77.6 % on test set. Finally, the 3PRule and multiclassifier were validated with 23 drugs in a Caco-2 assay. The rule is very useful to improve assay design and prioritize the high absorption candidates. Meanwhile the QSPR model exhibits appropriate classification performance. Due to the simplicity, easy interpretation and accuracy, the 3PRule and consensus model developed here can be used in early ADME profiling.</p></div>
]]></content:encoded><description>

During the early ADME profiling the development of simple, interpretable and reliable in silico tools is very important. In this study, rule-based and QSPR approaches were investigated using a large Caco-2 permeability database. Three permeability classes were determined: high (H), moderate (M) and low (L). The main physicochemical properties related with permeability were ranked as follows: Polar Surface Area (PSA)&gt;Lipophilicity (logP/logD)&gt;Molecular Weight (MW)&gt;number of Hydrogen Bond donors and acceptors&gt;Ionization State&gt;number of Rotatable Bonds&gt;number of Rings. The best rule, based on the combination of PSA-MW-logD (3PRule), was able to identify the H, M and L classes with accuracy of 72.2, 72.9 and 70.6 %, respectively. Subsequently, a consensus system based on three voting binary classification trees was constructed. It accurately predicted 78.4/76.1/79.1 % of H/M/L compounds on training and 78.6/71.1/77.6 % on test set. Finally, the 3PRule and multiclassifier were validated with 23 drugs in a Caco-2 assay. The rule is very useful to improve assay design and prioritize the high absorption candidates. Meanwhile the QSPR model exhibits appropriate classification performance. Due to the simplicity, easy interpretation and accuracy, the 3PRule and consensus model developed here can be used in early ADME profiling.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200167" xmlns="http://purl.org/rss/1.0/"><title>The Acid/Base Profile of the Human Metabolome and Natural Products</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200167</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The Acid/Base Profile of the Human Metabolome and Natural Products</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David T. Manallack, Matthew L. Dennis, Mark R. Kelly, Richard J. Prankerd, Elizabeth Yuriev, David K. Chalmers</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T15:12:10.900349-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200167</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200167</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200167</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Human small molecule metabolites (the human metabolome) are a set of compounds that interact with at least one macromolecule in the biosphere. This study investigates the acid/base profile of the human metabolome, natural products and drugs, together with an analysis of their physicochemical properties. Ionisation constants (p<em>K</em><sub>a</sub> values) are estimated for each compound and the identity of the ionisable functional groups in each set is determined. The acid/base and physicochemical property profile of the lipid component of the metabolome differed considerably to the other datasets. In contrast, the acid/base properties of non-lipid metabolites were found to be similar to both drugs and natural products. While the non-lipid metabolites have lower average <em>C</em>log<em>P</em> values and more hydrogen bond donors than the other datasets, the distribution of physicochemical property values overlapped considerably with the drug dataset. Considering also that the non-lipid metabolites are of biochemical interest, their characteristics have great potential to influence the selection of screening compounds for drug discovery.</p></div>
]]></content:encoded><description>

Human small molecule metabolites (the human metabolome) are a set of compounds that interact with at least one macromolecule in the biosphere. This study investigates the acid/base profile of the human metabolome, natural products and drugs, together with an analysis of their physicochemical properties. Ionisation constants (pKa values) are estimated for each compound and the identity of the ionisable functional groups in each set is determined. The acid/base and physicochemical property profile of the lipid component of the metabolome differed considerably to the other datasets. In contrast, the acid/base properties of non-lipid metabolites were found to be similar to both drugs and natural products. While the non-lipid metabolites have lower average ClogP values and more hydrogen bond donors than the other datasets, the distribution of physicochemical property values overlapped considerably with the drug dataset. Considering also that the non-lipid metabolites are of biochemical interest, their characteristics have great potential to influence the selection of screening compounds for drug discovery.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300004" xmlns="http://purl.org/rss/1.0/"><title>Information Theory and Voting Based Consensus Clustering for Combining Multiple Clusterings of Chemical Structures</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300004</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Information Theory and Voting Based Consensus Clustering for Combining Multiple Clusterings of Chemical Structures</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Faisal Saeed, Naomie Salim, Ammar Abdo</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T15:12:09.059679-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201300004</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201300004</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300004</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Many consensus clustering methods have been applied in different areas such as pattern recognition, machine learning, information theory and bioinformatics. However, few methods have been used for chemical compounds clustering. In this paper, an information theory and voting based algorithm (Adaptive Cumulative Voting-based Aggregation Algorithm A-CVAA) was examined for combining multiple clusterings of chemical structures. The effectiveness of clusterings was evaluated based on the ability of the clustering method to separate active from inactive molecules in each cluster, and the results were compared with Ward’s method. The chemical dataset MDL Drug Data Report (MDDR) and the Maximum Unbiased Validation (MUV) dataset were used. Experiments suggest that the adaptive cumulative voting-based consensus method can improve the effectiveness of combining multiple clusterings of chemical structures.</p></div>
]]></content:encoded><description>

Many consensus clustering methods have been applied in different areas such as pattern recognition, machine learning, information theory and bioinformatics. However, few methods have been used for chemical compounds clustering. In this paper, an information theory and voting based algorithm (Adaptive Cumulative Voting-based Aggregation Algorithm A-CVAA) was examined for combining multiple clusterings of chemical structures. The effectiveness of clusterings was evaluated based on the ability of the clustering method to separate active from inactive molecules in each cluster, and the results were compared with Ward’s method. The chemical dataset MDL Drug Data Report (MDDR) and the Maximum Unbiased Validation (MUV) dataset were used. Experiments suggest that the adaptive cumulative voting-based consensus method can improve the effectiveness of combining multiple clusterings of chemical structures.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300020" xmlns="http://purl.org/rss/1.0/"><title>Classification of High-Activity Tiagabine Analogs by Binary QSAR Modeling</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300020</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Classification of High-Activity Tiagabine Analogs by Binary QSAR Modeling</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andreas Jurik, Regina Reicherstorfer, Barbara Zdrazil, Gerhard F. Ecker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T15:12:04.562285-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201300020</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201300020</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300020</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Communication</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>███</p></div>
]]></content:encoded><description>

███
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200117" xmlns="http://purl.org/rss/1.0/"><title>Analysis of PPAR-α/γ Activity by Combining 2-D QSAR and Molecular Simulation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200117</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Analysis of PPAR-α/γ Activity by Combining 2-D QSAR and Molecular Simulation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Theodosia Vallianatou, George Lambrinidis, Costas Giaginis, Emmanuel Mikros, Anna Tsantili-Kakoulidou</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-15T11:13:24.941244-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200117</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200117</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200117</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In the present study 2D-QSAR analysis was combined with information on crystallographic data and molecular modeling, in order to investigate dual PPAR-α/γ activity for a data set of 71 compounds, compiled from literature. Using Multivariate Data Analysis, satisfactory PLS models were generated for each receptor subtype separately. The models were based on simple and easily interpretable drug-like and constitutional descriptors, while the inclusion of MOLCONN-Z descriptors in the initial pool of variables had no considerable impact in model predictivity. By simultaneous analysis of both types of activity, a consensus PLS model for dual PPAR-α/γ activity could be derived, displaying the molecular features, which may lead to a balanced activity. All models were validated by permutation tests, by dividing the data set into training and test sets, as well as by external validation using a blind test set. Detailed inspection of PPAR-α and PPAR-γ crystal structures and molecular simulation supported the differentiation of most important descriptors in the separate PLS models, e.g. the higher impact of lipophilicity and bulk descriptors in PPAR-α and PPAR-γ activity respectively, as well as the effect of specific structural descriptors. Molecular simulation provided also explanation for the behavior of certain outliers in the PLS models.</p></div>
]]></content:encoded><description>

In the present study 2D-QSAR analysis was combined with information on crystallographic data and molecular modeling, in order to investigate dual PPAR-α/γ activity for a data set of 71 compounds, compiled from literature. Using Multivariate Data Analysis, satisfactory PLS models were generated for each receptor subtype separately. The models were based on simple and easily interpretable drug-like and constitutional descriptors, while the inclusion of MOLCONN-Z descriptors in the initial pool of variables had no considerable impact in model predictivity. By simultaneous analysis of both types of activity, a consensus PLS model for dual PPAR-α/γ activity could be derived, displaying the molecular features, which may lead to a balanced activity. All models were validated by permutation tests, by dividing the data set into training and test sets, as well as by external validation using a blind test set. Detailed inspection of PPAR-α and PPAR-γ crystal structures and molecular simulation supported the differentiation of most important descriptors in the separate PLS models, e.g. the higher impact of lipophilicity and bulk descriptors in PPAR-α and PPAR-γ activity respectively, as well as the effect of specific structural descriptors. Molecular simulation provided also explanation for the behavior of certain outliers in the PLS models.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200120" xmlns="http://purl.org/rss/1.0/"><title>Activity Landscapes, Information Theory, and Structure – Activity Relationships</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200120</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Activity Landscapes, Information Theory, and Structure – Activity Relationships</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Preeti Iyer, Dagmar Stumpfe, Martin Vogt, J. Bajorath, G. M. Maggiora</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-27T09:10:42.569715-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200120</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200120</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200120</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Activity landscapes provide a comprehensive description of structure-activity relationships (SARs). An information theoretic assessment of their features, namely, activity cliffs, similarity cliffs, smooth-SAR, and featureless regions, is presented based on the probability of occurrence of these features. It is shown that activity cliffs provide highly informative SARs compared to smooth-SAR regions, although the latter are the basis for most QSAR studies. This follows since small structural changes in the former are coupled with relatively large changes in activity, thus pinpointing specific structural features associated with the changes in activity. In contrast, Smooth-SAR regions are typically associated with relatively small changes in both structure and activity. Surprisingly, similarity cliffs, which occur when both compounds in a compound-pair have approximately equal activities but significantly different structures, are the most prevalent feature of activity landscapes. Hence, from an information theoretic point of view, they are the least informative landscape feature. Nevertheless, similarity cliffs do provide SAR information on potentially new active compound classes, and in that sense they are quite useful in drug discovery programs since they provide alternative possibilities should ADMET or other issues arise during the discovery and earlier preclinical development phases of drug research.</p></div>
]]></content:encoded><description>

Activity landscapes provide a comprehensive description of structure-activity relationships (SARs). An information theoretic assessment of their features, namely, activity cliffs, similarity cliffs, smooth-SAR, and featureless regions, is presented based on the probability of occurrence of these features. It is shown that activity cliffs provide highly informative SARs compared to smooth-SAR regions, although the latter are the basis for most QSAR studies. This follows since small structural changes in the former are coupled with relatively large changes in activity, thus pinpointing specific structural features associated with the changes in activity. In contrast, Smooth-SAR regions are typically associated with relatively small changes in both structure and activity. Surprisingly, similarity cliffs, which occur when both compounds in a compound-pair have approximately equal activities but significantly different structures, are the most prevalent feature of activity landscapes. Hence, from an information theoretic point of view, they are the least informative landscape feature. Nevertheless, similarity cliffs do provide SAR information on potentially new active compound classes, and in that sense they are quite useful in drug discovery programs since they provide alternative possibilities should ADMET or other issues arise during the discovery and earlier preclinical development phases of drug research.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390007" xmlns="http://purl.org/rss/1.0/"><title>Cover Picture: (Mol. Inf. 4/2013)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390007</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cover Picture: (Mol. Inf. 4/2013)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T04:24:06.072276-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201390007</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201390007</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390007</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cover Picture</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">317</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">317</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201390007/asset/image_m/mcontent.gif?v=1&amp;s=c11c67e9503f907bbfc167a5a7505da0ded90821" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201390007/asset/image_n/ncontent.gif?v=1&amp;s=ee6f67280cddf0dfaeed5d48abb709598a69685b"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Molecular Informatics</em> publishes research that will deepen our understanding about information storage and processing on the molecular level, signaling and regulation of biological and chemical systems including cellular systems and macromolecular assemblies, modeling of molecular interactions and networks, and the design of molecular modulators that exhibit desired biochemical and pharmacological effects. Various aspects of this transdisciplinary scientific area are depicted on the cover: Cells with their nuclei and membranes (image courtesy of Dr. A. Schreiner and E. Resch), models of receptor-ligand interactions, and an artistic representation of “biological information” as multiple bit-codes presented on a right-handed helix.</p><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>Molecular Informatics publishes research that will deepen our understanding about information storage and processing on the molecular level, signaling and regulation of biological and chemical systems including cellular systems and macromolecular assemblies, modeling of molecular interactions and networks, and the design of molecular modulators that exhibit desired biochemical and pharmacological effects. Various aspects of this transdisciplinary scientific area are depicted on the cover: Cells with their nuclei and membranes (image courtesy of Dr. A. Schreiner and E. Resch), models of receptor-ligand interactions, and an artistic representation of “biological information” as multiple bit-codes presented on a right-handed helix.






</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390008" xmlns="http://purl.org/rss/1.0/"><title>Graphical Abstract: Mol. Inf. 4/2013</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390008</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Graphical Abstract: Mol. Inf. 4/2013</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T04:24:06.072276-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201390008</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201390008</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201390008</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Graphical Abstract</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">319</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">321</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300042" xmlns="http://purl.org/rss/1.0/"><title>Computational Resources for MHC Ligand Identification</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300042</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Computational Resources for MHC Ligand Identification</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christian P. Koch, Max Pillong, Jan A. Hiss, Gisbert Schneider</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-12T07:12:00.133029-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201300042</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201300042</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300042</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">326</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">336</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Advances in the high-throughput determination of functional modulators of major histocompatibility complex (MHC) and improved computational predictions of MHC ligands have rendered the rational design of immunomodulatory peptides feasible. Proteome-derived peptides and ‘reverse vaccinology’ by computational means will play a driving role in future vaccine design. Here we review the molecular mechanisms of the MHC mediated immune response, present the computational approaches that have emerged in this area of biotechnology, and provide an overview of publicly available computational resources for predicting and designing new peptidic MHC ligands.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201300042/asset/image_m/mcontent.gif?v=1&amp;s=3a0de8c801c9610e72f84002c51de871b846ca6b" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201300042/asset/image_n/ncontent.gif?v=1&amp;s=e510af2e8e3702f7d65cfed206f0581154a3b080"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

Advances in the high-throughput determination of functional modulators of major histocompatibility complex (MHC) and improved computational predictions of MHC ligands have rendered the rational design of immunomodulatory peptides feasible. Proteome-derived peptides and ‘reverse vaccinology’ by computational means will play a driving role in future vaccine design. Here we review the molecular mechanisms of the MHC mediated immune response, present the computational approaches that have emerged in this area of biotechnology, and provide an overview of publicly available computational resources for predicting and designing new peptidic MHC ligands.







</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200154" xmlns="http://purl.org/rss/1.0/"><title>A Crowd-Based Process and Tool for HTS Hit Triage</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200154</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A Crowd-Based Process and Tool for HTS Hit Triage</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Zhengwei Peng, Paul Gillespie, Martin Weisel, Sung-Sau So, W. Venus So, Rama Kondru, Arjun Narayanan, Johannes C. Hermann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T10:13:35.027497-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200154</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200154</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200154</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Communication</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">337</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">345</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201200154/asset/image_m/mcontent.gif?v=1&amp;s=0a788f4d1439fe0942bbbfdef62b4d3f6cf2e829" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201200154/asset/image_n/ncontent.gif?v=1&amp;s=fec8a95b8cef183d2cb4c82bece5e890c3c2b751"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>






</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200142" xmlns="http://purl.org/rss/1.0/"><title>Comparative Analysis of Cluster Validity Indices in Identifying Some Possible Genes Mediating Certain Cancers</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200142</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comparative Analysis of Cluster Validity Indices in Identifying Some Possible Genes Mediating Certain Cancers</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anupam Ghosh, Bibhas Chandra Dhara, Rajat K. De</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-08T14:31:30.173332-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200142</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200142</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200142</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">347</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">354</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In this article, we compare the performance of 19 cluster validity indices, in identifying some possible genes mediating certain cancers, based on gene expression data. For the purpose of this comparison, we have developed a method. The proposed method involves cluster generation, selection of the best <em>k</em>-value or <em>c</em>-values, cluster identification, identifying the altered gene cluster, scoring an altered gene cluster and determining the best <em>k</em>-value or <em>c</em>-value exploring through biological repositories. The effectiveness of the method has been demonstrated on three gene expression data sets dealing with human lung cancer, colon cancer, and leukemia. Here, we have used three clustering algorithms, i.e., <em>k</em>-means, PAM and fuzzy <em>c</em>-means. We have used biochemical pathways related to these cancers and <em>p</em>-value statistics for validating the study.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201200142/asset/image_m/mcontent.gif?v=1&amp;s=ae7aeee05155e468cc3f07c991252f05485407ce" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201200142/asset/image_n/ncontent.gif?v=1&amp;s=8de283b5630159955907793fd901b8368d775a23"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

In this article, we compare the performance of 19 cluster validity indices, in identifying some possible genes mediating certain cancers, based on gene expression data. For the purpose of this comparison, we have developed a method. The proposed method involves cluster generation, selection of the best k-value or c-values, cluster identification, identifying the altered gene cluster, scoring an altered gene cluster and determining the best k-value or c-value exploring through biological repositories. The effectiveness of the method has been demonstrated on three gene expression data sets dealing with human lung cancer, colon cancer, and leukemia. Here, we have used three clustering algorithms, i.e., k-means, PAM and fuzzy c-means. We have used biochemical pathways related to these cancers and p-value statistics for validating the study.







</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300006" xmlns="http://purl.org/rss/1.0/"><title>Structural Key Bit Occurrence Frequencies and Dependencies in PubChem and Their Effect on Similarity Searches</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300006</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Structural Key Bit Occurrence Frequencies and Dependencies in PubChem and Their Effect on Similarity Searches</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nelson G. Chen, Val Golovlev</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T07:41:22.741486-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201300006</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201300006</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300006</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">355</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">361</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Little published literature exists on the 881 bit structural keys used by PubChem for categorizing and comparing the compounds present in its database. We characterized these structural keys by examining their frequencies of occurrence within the PubChem compound database. In addition, bit dependencies, defined as the universal presence of a bit given the presence of another, were determined. We show that the vast majority of bits are rarely set and that substantial numbers of dependencies exist. A comparison of similarity searches with five United States Food and Drug Administration approved drugs as reference compounds using the full structural keys versus a variant in which all dependent bits were removed was performed using the Tanimoto coefficient. These bit dependencies not only affect similarity scores, but also alter the compounds returned in similarity searching. Judicious selection of bits is needed to maintain sufficient ability to differentiate related compounds.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201300006/asset/image_m/mcontent.gif?v=1&amp;s=a626426c5f3cbc8d6740fcecf7f263bc753d7342" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201300006/asset/image_n/ncontent.gif?v=1&amp;s=11c7c3db067dd2a8f8c1deb0f2c09c235c7f3d6d"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

Little published literature exists on the 881 bit structural keys used by PubChem for categorizing and comparing the compounds present in its database. We characterized these structural keys by examining their frequencies of occurrence within the PubChem compound database. In addition, bit dependencies, defined as the universal presence of a bit given the presence of another, were determined. We show that the vast majority of bits are rarely set and that substantial numbers of dependencies exist. A comparison of similarity searches with five United States Food and Drug Administration approved drugs as reference compounds using the full structural keys versus a variant in which all dependent bits were removed was performed using the Tanimoto coefficient. These bit dependencies not only affect similarity scores, but also alter the compounds returned in similarity searching. Judicious selection of bits is needed to maintain sufficient ability to differentiate related compounds.







</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300008" xmlns="http://purl.org/rss/1.0/"><title>Predicting pKa Values in Aqueous Solution for the Guanidine Functional Group from Gas Phase Ab Initio Bond Lengths</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300008</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Predicting pKa Values in Aqueous Solution for the Guanidine Functional Group from Gas Phase Ab Initio Bond Lengths</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mark Z. Griffiths, Ibon Alkorta, Paul L. A. Popelier</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T10:13:27.378136-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201300008</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201300008</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201300008</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">363</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">376</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Here we applied a novel method<a href="#bib1a" rel="references:#bib1a">1a</a> to predict p<em>K</em><sub>a</sub> values of the guanidine functional group, which is a notoriously difficult. This method, which was developed in our lab, uses only one ab initio bond length obtained at a low level of theory. The method is shown to work for drug molecules, delivers prediction errors of less than 0.5 log units, successfully treats tautomerisation in close relation with experiment, and demonstrates strong correlations with only a few data points. The high structural content of the ab initio bond length makes a given data set essentially divide itself into <em>high correlation subsets.</em> One then observes that molecules within a subset possess a common substructure. Each high correlation subset exists in its own region of chemical space. The high correlation subset method is explored with respect to this position in chemical space, in particular tautomerisation. The proposed method is able to distinguish between different tautomeric forms and the preferred tautomeric form emerges naturally, in agreement with experiment.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201300008/asset/image_m/mcontent.gif?v=1&amp;s=09a11f2e9127878d8dbde5f4571752453befe9e5" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201300008/asset/image_n/ncontent.gif?v=1&amp;s=30fe0256c53a16a2ea69f11b31cfdb51ce3351dd"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

Here we applied a novel method1a to predict pKa values of the guanidine functional group, which is a notoriously difficult. This method, which was developed in our lab, uses only one ab initio bond length obtained at a low level of theory. The method is shown to work for drug molecules, delivers prediction errors of less than 0.5 log units, successfully treats tautomerisation in close relation with experiment, and demonstrates strong correlations with only a few data points. The high structural content of the ab initio bond length makes a given data set essentially divide itself into high correlation subsets. One then observes that molecules within a subset possess a common substructure. Each high correlation subset exists in its own region of chemical space. The high correlation subset method is explored with respect to this position in chemical space, in particular tautomerisation. The proposed method is able to distinguish between different tautomeric forms and the preferred tautomeric form emerges naturally, in agreement with experiment.







</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200128" xmlns="http://purl.org/rss/1.0/"><title>Molecular Modeling and Active Site Binding Mode Characterization of Aspartate β-Semialdehyde Dehydrogenase Family </title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200128</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Molecular Modeling and Active Site Binding Mode Characterization of Aspartate β-Semialdehyde Dehydrogenase Family </dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rajender Kumar, Prabha Garg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T10:13:31.503146-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200128</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200128</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200128</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">377</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">383</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The enzyme aspartate β-semialdehyde dehydrogenase (ASADH) plays a vital role in biosynthesis of essential amino acids and several important metabolites in microbes and some higher plants. So this key enzyme can be targeted selectively in these microbes to exhibit anti-bacterial and fungicidal effects. In this work, molecular modeling and comparative active site binding mode studies were performed for understanding the mode of action, in silico insight into the 3D structure, enzyme-substrate interactions with natural substrate in this homologous enzyme family. During comparative sequence analysis, high diversity was found in the sequences of different ASADHs and exhibited the same key binding interactions with the substrate. Both, the functional carboxylic and the phosphate group of the substrate are engaged in a bidentate interaction with the guanidinium N atom of two key arginyl active site residues of ASADHs. These structural and active site binding mode characterization studies can further be used for designing the more potent and selective substrate analogues inhibitors against ASADH family.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201200128/asset/image_m/mcontent.gif?v=1&amp;s=6bae9129110dc99e585958af97b381e70dc22752" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201200128/asset/image_n/ncontent.gif?v=1&amp;s=01ec56068eabf684d48a5254ab4ccdc1e89a21ce"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

The enzyme aspartate β-semialdehyde dehydrogenase (ASADH) plays a vital role in biosynthesis of essential amino acids and several important metabolites in microbes and some higher plants. So this key enzyme can be targeted selectively in these microbes to exhibit anti-bacterial and fungicidal effects. In this work, molecular modeling and comparative active site binding mode studies were performed for understanding the mode of action, in silico insight into the 3D structure, enzyme-substrate interactions with natural substrate in this homologous enzyme family. During comparative sequence analysis, high diversity was found in the sequences of different ASADHs and exhibited the same key binding interactions with the substrate. Both, the functional carboxylic and the phosphate group of the substrate are engaged in a bidentate interaction with the guanidinium N atom of two key arginyl active site residues of ASADHs. These structural and active site binding mode characterization studies can further be used for designing the more potent and selective substrate analogues inhibitors against ASADH family.







</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200169" xmlns="http://purl.org/rss/1.0/"><title>Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200169</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multiple e-Pharmacophore Modeling Combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of β-Secretase(BACE1)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ravichand Palakurti, Dharmarajan Sriram, Perumal Yogeeswari, Ramakrishna Vadrevu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-15T11:13:18.967815-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/minf.201200169</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/minf.201200169</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fminf.201200169</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Full Paper</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">385</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">398</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>β-Secretase (BACE1) is an aspartate protease involved in the production of amyloid-β a major peptide responsible for the pathogenesis of Alzheimer’s disease. Given its role in the formation of amyloids leading to Alzheimer’s disease, it has been a major therapeutic target for intervention and has been a challenge in the past and the progress has been very slow. More than hundred crystal structures with inhibitors are available in the protein data bank. Many strategies for drug design have been employed in the design of numerous diverse ligands for this target and many have failed due to undesirable drug properties primarily the inability to cross the blood-brain barrier. In the present work we attempted to consider multiple crystal structures with bound inhibitors showing affinity in the range of 2–210 nM efficacy and optimize the pharmacophoric requirement based on the energy involved in binding termed as e-pharmacophore mapping. A high throughput screening combined with molecular docking, ADMET predictions, log<em>P</em> values and in vitro assay led to the identification of 7 potential compounds showing inhibition at 10µM which could be further developed as novel inhibitors for β-secretase.</p></div>
<a title="Link to full-size graphical abstract" class="figZoom" href="http://onlinelibrary.wiley.com/store/10.1002/minf.201200169/asset/image_m/mcontent.gif?v=1&amp;s=ea51f7a98491898de418a935a293f4120d0662fd" xmlns="http://www.w3.org/1999/xhtml"><img alt="Thumbnail image of graphical abstract" title="Thumbnail image of graphical abstract" src="http://onlinelibrary.wiley.com/store/10.1002/minf.201200169/asset/image_n/ncontent.gif?v=1&amp;s=90b5ab955836ab65a91793cc5b5b040f74529f98"/></a>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><!--Unmatched element: w:blockFixed--></div>
]]></content:encoded><description>

β-Secretase (BACE1) is an aspartate protease involved in the production of amyloid-β a major peptide responsible for the pathogenesis of Alzheimer’s disease. Given its role in the formation of amyloids leading to Alzheimer’s disease, it has been a major therapeutic target for intervention and has been a challenge in the past and the progress has been very slow. More than hundred crystal structures with inhibitors are available in the protein data bank. Many strategies for drug design have been employed in the design of numerous diverse ligands for this target and many have failed due to undesirable drug properties primarily the inability to cross the blood-brain barrier. In the present work we attempted to consider multiple crystal structures with bound inhibitors showing affinity in the range of 2–210 nM efficacy and optimize the pharmacophoric requirement based on the energy involved in binding termed as e-pharmacophore mapping. A high throughput screening combined with molecular docking, ADMET predictions, logP values and in vitro assay led to the identification of 7 potential compounds showing inhibition at 10µM which could be further developed as novel inhibitors for β-secretase.







</description></item></rdf:RDF>